Current Roles
AI & Cell Therapy
Business Scientist
CellVoyant, founded by Rafael Carazo Salas, is a University of Bristol spinout leading a transformative approach in stem cell-based therapy manufacturing. By integrating novel technologies, CellVoyant aims to produce therapies that are efficient, safe, and tailored to individual patient needs, addressing the current slow and inefficient methods plaguing the industry.
Leveraging a combination of large-scale cell culture, live cell imaging, and data-driven computer vision, CellVoyant optimises stem cell differentiation in real time. This breakthrough allows for the precise programming of stem cells into desired adult cell types, marking a significant leap forward from traditional, error-prone methods.
Based in Bristol, UK, CellVoyant operates a hybrid model, fostering a culture of innovation and creativity among its team. With a strong focus on collaboration, diversity, and inclusivity, the company is committed to building a vibrant and impactful workplace.
CellVoyant's ethical framework is built on integrity, transparency, and accountability, principles that guide its pursuit of developing life-changing therapies. The company's successful £7.6m seed funding round reflects confidence in its potential to revolutionise stem cell therapy for conditions beyond cancer, including diabetes and potentially dementia, promising a future where effective treatments are more readily available.
Interested in working for Cellvoyant? Contact Richard for more information.
Meet the Founder
Rafael Carazo Salas
CEO & Founder
Chair in Biomedical Sciences at the School of Cellular and Molecular Medicine, Bristol University
Big Data & Stem Cell Scientist working to make predictive, data driven and stem cell therapeutics realities.
Meet the Team
Edward Ren
Imaging Scientist
Saad Mohamad
ML/AI
Science Lead
Elisa Pedone
Stem Cell
Operations Lead
Robert van Dijk
Machine Learning
Researcher
Karunya
Balasubramaniam
Laboratory
Technician
Rich Lee
Head of Business Development and Commercialisation
Joe Peskett
ML Operations
Lucy Templeman
Executive Assistant to the CEO
Rickard Sjögren
Applied ML Scientist
Tunde Berecz
Stem Cell Scientist
Cellvoyant Articles
Octopus-backed AI biotech CellVoyant raises £7.6m to make stem cell therapies cheaper
An article from Sifted (2024).